Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Was excited.

<< Previous

Bullboard Posts

Next >>

Comment by Dude51on Apr 01, 2021 10:21am

119 Views

Post# 32922283

RE:RE:RE:Was excited.

We all want it to go but were being shorted. Have we had any bad news since since the unhalting of the halt? None that I could find. Take yesterday, it was mostly an up day then one dipshiit sells over 400 thousand shares and drives the price down. There keeping demand down because we always seem to be going down since we hit the high of 11 cents March 1st. Wait for more news from our canary in the gold mine, SaNOtize.

my two cents

<< Previous

Bullboard Posts

Next >>

AI companies to invest in